Stop for Stress - a Randomized Controlled Trial Comparing an Online and a Group-based Format of an Intervention for Work-related Stress

June 13, 2025 updated by: Lea Nørgaard Sørensen

Stop for Stress - En Sammenligning af Online og Gruppebaseret Behandling for Arbejdsrelateret Stress

Work-related stress is a major public health concern, causing sickness absenteeism and impaired health and well-being. Many afflicted with severe work-related stress will not receive evidence-based treatment due to geographical distance, stigma and unwillingness to participate in a group, creating unequality access to healthcare services. Online interventions show comparable effects to face-to-face interventions and have potential to break down some of these barriers. We have developed and pilot tested the online delivery format of the intervention for work-related stress, Stop for Stress, with promising results. In a two-armed, multicentre randomized controlled trial we aim to 1) compare the effect of the online delivery format and an evidence-based face-to-face group-based format and 2) identify markers of enhanced outcomes in each delivery format. The study will include 220 patients with severe work-related stress (110 from each of two centres) who are randomizes 1:1 to the two interventions. Outcomes consist of self-report measures of psychological symptoms, cognitive functioning, sleep, and perceived working environment and register data on ebsenteeism and return-to-work.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

220

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Lea N Sørensen, MSc Psychology
  • Phone Number: +45 61369464
  • Email: leanso@rm.dk

Study Contact Backup

  • Name: Zara A Stokholm, MD, PhD
  • Phone Number: +45 61369464
  • Email: zarastok@rm.dk

Study Locations

    • Central Region Denmark
      • Aarhus, Central Region Denmark, Denmark, 8200
        • Recruiting
        • Department of Occupational and Environmental Medicine, Aarhus University Hospital
        • Contact:
          • Lea N Sørensen, MSc Psychology
          • Phone Number: +45 61369464
          • Email: leanso@rm.dk
        • Contact:
          • Zara A Stokholm, MD, PhD
          • Phone Number: +45 61369464
          • Email: zarastok@rm.dk
      • Herning, Central Region Denmark, Denmark, 7400
        • Not yet recruiting
        • Department of Occupational and Environmental Medicine, Gødstrup Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Current employment and significant work-related stressors
  • Perceived Stress Scale (PSS-10) score ≥20 and symptom duration >4 weeks
  • In case of full-time sick leave, return to work must be planned concurrent with the intervention
  • Access to a computer or tablet with internet connection at home

Exclusion Criteria:

  • Interpersonal difficulties, bullying, harassment, violence, threats, and traumatic events as primary stressor
  • Severe stressors outside of work
  • Symptoms meeting diagnostic criteria for anxiety, depression or severe psychiatric illnesses requiring specialized treatment
  • Current abuse of alcohol and/or psychoactive drugs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Therapist-assisted online delivery format
Participants will gain access to an online program comprised by 14 modules covering psychoeducation on stress, sleep, and communication, cognitive behavioral restructuring, and exercises and tools for dealing with stress and preventing relapse. Participants are followed by a therapist providing feedback on exercises and progress. The program extends over approx. 12 weeks.
Participants gain access to an online program comprised by 14 modules covering psychoeducation on stress, sleep, and communication, cognitive behavioral restructuring, and exercises and tools for dealing with stress and preventing relapse. Participants are followed by a therapist providing feedback on exercises and progress. The program extends over approx. 12 weeks.
Other Names:
  • Stop for Stress
Active Comparator: Group-based face-to-face delivery format
The group-based format consists of 8 sessions of each 3 hours spread across 12 weeks. The sessions cover psychoeducation on stress, sleep, and communication, cognitive behavioral restructuring, and exercises and tools for dealing with stress and preventing relaps. A group includes 8-9 participants
The group-based format consists of 8 sessions of each 3 hours spread across 12 weeks. The sessions cover psychoeducation on stress, sleep, and communication, cognitive behavioral restructuring, and exercises and tools for dealing with stress and preventing relaps. A group includes 8-9 participants
Other Names:
  • MARS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Return-to-work
Time Frame: Participants are followed continously from 5 yeras prior to enrollment (baseline) and until 12 months follow-up
Derived from the Danish national DREAM registry, comprising information on weekly transfer income (e.g. long-term sickness absence) and employment status
Participants are followed continously from 5 yeras prior to enrollment (baseline) and until 12 months follow-up
Perceived stress (T1)
Time Frame: Post intervention: 3 months from baseline
Self-report measure using the 10 item Perceived Stress Scale (PSS-10), 10 items on a 0-4 scale, ranging from 0-40 point with higher scores indicating more perceived stress.
Post intervention: 3 months from baseline
Obejctive cognitive functioning measures by ICAT (T2)
Time Frame: Follow-up: 6 months from baseline
ICAT (Internet-Based Cognitive Assessment Tool) comprises 5 subtests (list learning, consonant repitition, letter-number sequencing, delayed list learning, visuomotor tracking)
Follow-up: 6 months from baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Working environment (T1)
Time Frame: Post intervention: 3 months from baseline
Perceived working environment self-reported using selected (independent) items from the Danish Psychosocial Questionnaire (DPQ). Includes influence, predictability, work load, relations to coworkers, relations to managers, recognition, and meaning.
Post intervention: 3 months from baseline
Working environment (T2)
Time Frame: Follow-up: 6 months from baseline
Perceived working environment self-reported using selected (independent) items from the Danish Psychosocial Questionnaire (DPQ). Includes influence, predictability, work load, relations to coworkers, relations to managers, recognition, and meaning.
Follow-up: 6 months from baseline
Perceived Stress (T2)
Time Frame: Follow-up: 6 months from baseline
Self-report measure using the 10 item Perceived Stress Scale (PSS-10), 10 items on a 0-4 scale, ranging from 0-40 point with higher scores indicating more perceived stress.
Follow-up: 6 months from baseline
Perceived Stress (T3)
Time Frame: Follow-up: 12 months from baseline
Self-report measure using the 10 item Perceived Stress Scale (PSS-10), 10 items on a 0-4 scale, ranging from 0-40 point with higher scores indicating more perceived stress.
Follow-up: 12 months from baseline
Cognitive functioning (T1)
Time Frame: Post intervention: 3 months from baseline
Self-report measure using the Cognitive Failures Questionnaire (CFQ), 25 items on a 0-4 point scale, range 0-100 with higher scores indicating lower subjective cognitive functioning.
Post intervention: 3 months from baseline
Work ability (T1)
Time Frame: Post intervention: 3 months from baseline
Self-report measure using the Work Ability Index (WAI), 1 item scale ranging from 0-10 with higher scores indicating better work ability
Post intervention: 3 months from baseline
Work ability (T2)
Time Frame: Follow-up: 6 months from baseline
Self-report measure using the Work Ability Index (WAI), 1 item scale ranging from 0-10 with higher scores indicating better work ability
Follow-up: 6 months from baseline
Work ability (T3)
Time Frame: Follow-up: 12 months from baseline
Self-report measure using the Work Ability Index (WAI), 1 item scale ranging from 0-10 with higher scores indicating better work ability
Follow-up: 12 months from baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Working environment (T3)
Time Frame: Follow-up: 12 months from baseline
Perceived working environment self-reported using selected (independent) items from the Danish Psychosocial Questionnaire (DPQ). Includes influence, predictability, work load, relations to coworkers, relations to managers, recognition, and meaning.
Follow-up: 12 months from baseline
Utilizations of psychotropic drug prescriptions
Time Frame: Participants are followed continously from 5 yeras prior to enrollment (baseline) and until 12 months follow-up
Derived from the Danish national Register of Medical Products Statistics. Includes presciptions on antidepressants, anxiolytics, sedatives and anagesics.
Participants are followed continously from 5 yeras prior to enrollment (baseline) and until 12 months follow-up
Sleep quality (T1)
Time Frame: Post intervention: 3 months from baseline
Self-report measure using the Basic Nordic Sleep Questionnaire (BSNQ), 7 items on a 1-5 scale, ranging from 7-35 points with higher scores indicating lower subjective sleep quality
Post intervention: 3 months from baseline
Sleep quality (T2)
Time Frame: Follow-up: 6 months from baseline
Self-report measure using the Basic Nordic Sleep Questionnaire (BSNQ), 7 items on a 1-5 scale, ranging from 7-35 points with higher scores indicating lower subjective sleep quality
Follow-up: 6 months from baseline
Sleep quality (T3)
Time Frame: Follow-up: 12 months from baseline
Self-report measure using the Basic Nordic Sleep Questionnaire (BSNQ), 7 items on a 1-5 scale, ranging from 7-35 points with higher scores indicating lower subjective sleep quality
Follow-up: 12 months from baseline
Symptoms of depression and anxiety (T1)
Time Frame: Post intervention: 3 months from baseline
Self-report measure using the Common Mental Disorders Questionniare (CMDQ), 10 items in total: 4 item on the anxiety scale (0-4 point scale, range 0-16) and 6 items on the depression scale (0-4 point scale, range 0-24) with higher scores indicating more severe symptoms.
Post intervention: 3 months from baseline
Symptoms of depression and axiety (T2)
Time Frame: Follow-up: 6 months from baseline
Self-report measure using the Common Mental Disorders Questionniare (CMDQ), 10 items in total: 4 item on the anxiety scale (0-4 point scale, range 0-16) and 6 items on the depression scale (0-4 point scale, range 0-24) with higher scores indicating more severe symptoms.
Follow-up: 6 months from baseline
Symptoms of depression and anxiety (T3)
Time Frame: Follow-up: 12 months from baseline
Self-report measure using the Common Mental Disorders Questionniare (CMDQ), 10 items in total: 4 item on the anxiety scale (0-4 point scale, range 0-16) and 6 items on the depression scale (0-4 point scale, range 0-24) with higher scores indicating more severe symptoms.
Follow-up: 12 months from baseline
Cognitive functioning (T2)
Time Frame: Follow-up: 6 months from baseline
Self-reportmeasure using the Cognitive Failures Questionnaire (CFQ), 25 items on a 0-4 point scale, range 0-100 with higher scores indicating lower subjective cognitive functioning.
Follow-up: 6 months from baseline
Cognitive functioning (T3)
Time Frame: Follow-up: 12 months from baseline
Self-reportmeasure using the Cognitive Failures Questionnaire (CFQ), 25 items on a 0-4 point scale, range 0-100 with higher scores indicating lower subjective cognitive functioning.
Follow-up: 12 months from baseline
Daily functioning (T1)
Time Frame: Post intervention: 3 months from baseline
Self-report measure using the Work and Social Adjustment Scale (WSAS), 5 items 0-8 point scale, ranging from 0-40 point, where higher scores indicate more impaired daily functioning.
Post intervention: 3 months from baseline
Daily functioning (T2)
Time Frame: Follow-up: 6 months from baseline
Self-report measure using the Work and Social Adjustment Scale (WSAS), 5 items 0-8 point scale, ranging from 0-40 point, where higher scores indicate more impaired daily functioning.
Follow-up: 6 months from baseline
Daily functioning (T3)
Time Frame: Follow-up: 12 months from baseline
Self-report measure using the Work and Social Adjustment Scale (WSAS), 5 items 0-8 point scale, ranging from 0-40 point, where higher scores indicate more impaired daily functioning.
Follow-up: 12 months from baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Zara A Stokholm, MD, PhD, Department of Occupational and Environmental Medicine, Danish Ramazzini Centre, Aarhus University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 27, 2025

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

August 1, 2027

Study Registration Dates

First Submitted

January 23, 2025

First Submitted That Met QC Criteria

January 23, 2025

First Posted (Actual)

January 29, 2025

Study Record Updates

Last Update Posted (Actual)

June 17, 2025

Last Update Submitted That Met QC Criteria

June 13, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Work-Related Stress

Clinical Trials on Therapist-assisted online stress management

Subscribe